anmelden
FTSE All-Share
5.826,09
PKT
-40,50
PKT
-0,69
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.04.20 | Lloyds Banking Group overweight | Barclays Capital | |
| 16.04.20 | Unilever Hold | HSBC | |
| 16.04.20 | Vodafone Group buy | Jefferies & Company Inc. | |
| 15.04.20 | Prudential buy | UBS AG | |
| 15.04.20 | Diageo Outperform | Bernstein Research | |
| 15.04.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.04.20 | Lloyds Banking Group buy | Jefferies & Company Inc. | |
| 15.04.20 | BAT Outperform | Credit Suisse Group | |
| 15.04.20 | Unilever Outperform | Credit Suisse Group | |
| 14.04.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.04.20 | AstraZeneca buy | Deutsche Bank AG | |
| 14.04.20 | Diageo buy | Kepler Cheuvreux | |
| 14.04.20 | National Grid kaufen | Barclays Capital | |
| 14.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.04.20 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 09.04.20 | Diageo market-perform | Bernstein Research | |
| 09.04.20 | Diageo Hold | Jefferies & Company Inc. | |
| 09.04.20 | Diageo buy | Goldman Sachs Group Inc. | |
| 09.04.20 | HSBC Neutral | Credit Suisse Group | |
| 09.04.20 | AstraZeneca overweight | Barclays Capital | |
| 09.04.20 | GSK Underweight | Barclays Capital | |
| 09.04.20 | Barclays Neutral | Credit Suisse Group | |
| 09.04.20 | Prudential Outperform | Credit Suisse Group | |
| 09.04.20 | Lloyds Banking Group Neutral | Credit Suisse Group | |
| 09.04.20 | London Stock Exchange (LSE) Hold | Deutsche Bank AG | |
| 08.04.20 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 08.04.20 | Vodafone Group overweight | Barclays Capital | |
| 08.04.20 | Unilever Hold | HSBC | |
| 08.04.20 | BT Group buy | Jefferies & Company Inc. | |
| 07.04.20 | BP Neutral | Credit Suisse Group | |
| 07.04.20 | National Grid buy | UBS AG | |
| 07.04.20 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 07.04.20 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 07.04.20 | BP buy | UBS AG | |
| 07.04.20 | Rio Tinto verkaufen | Credit Suisse Group | |
| 07.04.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.04.20 | GSK buy | Goldman Sachs Group Inc. | |
| 07.04.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.04.20 | National Grid Outperform | RBC Capital Markets | |
| 07.04.20 | Vodafone Group overweight | JP Morgan Chase & Co. |
